|
1
|
Hartong DT, Berson EL and Dryja TP:
Retinitis pigmentosa. Lancet. 368:1795–1809. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
den Hollander AI, Black A, Bennett J and
Cremers FP: Lighting a candle in the dark: advances in genetics and
gene therapy of recessive retinal dystrophies. J Clin Invest.
120:3042–3053. 2010.PubMed/NCBI
|
|
3
|
Xu Y, Guan L, Shen T, Zhang J, Xiao X,
Jiang H, Li S, Yang J, Jia X, Yin Y, Guo X, Wang J and Zhang Q:
Mutations of 60 known causative genes in 157 families with
retinitis pigmentosa based on exome sequencing. Hum Genet. (In
press).
|
|
4
|
Züchner S, Dallman J, Wen R, et al:
Whole-exome sequencing links a variant in DHDDS to retinitis
pigmentosa. Am J Hum Genet. 88:201–206. 2011.PubMed/NCBI
|
|
5
|
Tucker BA, Scheetz TE, Mullins RF, et al:
Exome sequencing and analysis of induced pluripotent stem cells
identify the cilia-related gene male germ cell-associated kinase
(MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci USA.
108:E569–E576. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peluso I, Conte I, Testa F, et al: The
ADAMTS18 gene is responsible for autosomal recessive early onset
severe retinal dystrophy. Orphanet J Rare Dis. 8:162013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Webb TR, Parfitt DA, Gardner JC, et al:
Deep intronic mutation in OFD1, identified by targeted genomic
next-generation sequencing, causes a severe form of X-linked
retinitis pigmentosa (RP23). Hum Mol Genet. 21:3647–3654. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Guo L, Cai SP, et al: Exome
sequencing identifies compound heterozygous mutations in CYP4V2 in
a pedigree with retinitis pigmentosa. PLoS One. 7:e336732012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cremers FP, van de Pol DJ, van Kerkhoff
LP, Wieringa B and Ropers HH: Cloning of a gene that is rearranged
in patients with choroideraemia. Nature. 347:674–677. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rak A, Pylypenko O, Niculae A, Pyatkov K,
Goody RS and Alexandrov K: Structure of the Rab7:REP-1 complex:
insights into the mechanism of Rab prenylation and choroideremia
disease. Cell. 117:749–760. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seabra MC, Brown MS and Goldstein JL:
Retinal degeneration in choroideremia: deficiency of rab
geranylgeranyl transferase. Science. 259:377–381. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berger W, Kloeckener-Gruissem B and
Neidhardt J: The molecular basis of human retinal and vitreoretinal
diseases. Prog Retin Eye Res. 29:335–375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Q, Zulfiqar F, Xiao X, et al: Severe
autosomal recessive retinitis pigmentosa maps to chromosome
1p13.3-p21.2 between D1S2896 and D1S457 but outside ABCA4. Hum
Genet. 118:356–365. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao X, Li S, Guo X and Zhang Q: A novel
locus for autosomal dominant congenital motor nystagmus mapped to
1q31–q32.2 between D1S2816 and D1S2692. Hum Genet. 131:697–702.
2012.PubMed/NCBI
|
|
15
|
Li Y, Vinckenbosch N, Tian G, et al:
Resequencing of 200 human exomes identifies an excess of
low-frequency non-synonymous coding variants. Nat Genet.
42:969–972. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li R, Li Y, Kristiansen K and Wang J:
SOAP: short oligonucleotide alignment program. Bioinformatics.
24:713–714. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li R, Yu C, Li Y, et al: SOAP2: an
improved ultrafast tool for short read alignment. Bioinformatics.
25:1966–1967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li R, Li Y, Fang X, et al: SNP detection
for massively parallel whole-genome resequencing. Genome Res.
19:1124–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chi JY, MacDonald IM and Hume S: Copy
number variant analysis in CHM to detect duplications underlying
choroideremia. Ophthalmic Genet. 34:229–233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Coussa RG and Traboulsi EI: Choroideremia:
a review of general findings and pathogenesis. Ophthalmic Genet.
33:57–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esposito G, De Falco F, Tinto N, et al:
Comprehensive mutation analysis (20 families) of the choroideremia
gene reveals a missense variant that prevents the binding of REP1
with Rab geranylgeranyl transferase. Hum Mutat. 32:1460–1469. 2011.
View Article : Google Scholar
|
|
22
|
Forsythe P, Maguire A, Fujita R, Moen C,
Swaroop A and Bennett J: A carboxy-terminal truncation of 99 amino
acids resulting from a novel mutation (Arg555→stop) in the CHM gene
leads to choroideremia. Exp Eye Res. 64:487–490. 1997.PubMed/NCBI
|
|
23
|
Fujiki K, Hotta Y, Hayakawa M, et al:
REP-1 gene mutations in Japanese patients with choroideremia.
Graefes Arch Clin Exp Ophthalmol. 237:735–740. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garcia-Hoyos M, Lorda-Sanchez I,
Gómez-Garre P, et al: New type of mutations in three Spanish
families with choroideremia. Invest Ophthalmol Vis Sci.
49:1315–1321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hotta Y, Fujiki K, Hayakawa M, et al: A
hemizygous A to CC base change of the CHM gene causing
choroideremia associated with pinealoma. Graefes Arch Clin Exp
Ophthalmol. 235:653–655. 1997. View Article : Google Scholar
|
|
26
|
Iino Y, Fujimaki T, Fujiki K and Murakami
A: A novel mutation (967–970+2)delAAAGGT in the choroideremia gene
found in a Japanese family and related clinical findings. Jpn J
Ophthalmol. 52:289–297. 2008.
|
|
27
|
Itabashi T, Wada Y, Kawamura M, Sato H and
Tamai M: Clinical features of Japanese families with a 402delT or a
555–556delAG mutation in choroideremia gene. Retina. 24:940–945.
2004.
|
|
28
|
McTaggart KE, Tran M, Mah DY, Lai SW,
Nesslinger NJ and MacDonald IM: Mutational analysis of patients
with the diagnosis of choroideremia. Hum Mutat. 20:189–196. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nesslinger N, Mitchell G, Strasberg P and
MacDonald IM: Mutation analysis in Canadian families with
choroideremia. Ophthalmic Genet. 17:47–52. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Perez-Cano HJ, Garnica-Hayashi RE and
Zenteno JC: CHM gene molecular analysis and X-chromosome
inactivation pattern determination in two families with
choroideremia. Am J Med Genet A. 149A:2134–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ponjavic V, Abrahamson M, Andreasson S, et
al: Phenotype variations within a choroideremia family lacking the
entire CHM gene. Ophthalmic Genet. 16:143–150. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sankila EM, Tolvanen R, van den Hurk JA,
Cremers FP and de la Chapelle A: Aberrant splicing of the CHM gene
is a significant cause of choroideremia. Nat Genet. 1:109–113.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schwartz M, Rosenberg T, van den Hurk JA,
van de Pol DJ and Cremers FP: Identification of mutations in Danish
choroideremia families. Hum Mutat. 2:43–47. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
van Bokhoven H, Schwartz M, Andréasson S,
et al: Mutation spectrum in the CHM gene of Danish and Swedish
choroideremia patients. Hum Mol Genet. 3:1047–1051. 1994.
|
|
35
|
Yip SP, Cheung TS, Chu MY, et al: Novel
truncating mutations of the CHM gene in Chinese patients with
choroideremia. Mol Vis. 13:2183–2193. 2007.PubMed/NCBI
|
|
36
|
Zhou Q, Liu L, Xu F, et al: Genetic and
phenotypic characteristics of three Mainland Chinese families with
choroideremia. Mol Vis. 18:309–316. 2012.PubMed/NCBI
|
|
37
|
Lin Y, Liu X, Luo L, et al: Molecular
analysis of the choroideremia gene related clinical findings in two
families with choroideremia. Mol Vis. 17:2564–2569. 2011.PubMed/NCBI
|
|
38
|
Sergeev YV, Smaoui N, Sui R, et al: The
functional effect of pathogenic mutations in Rab escort protein 1.
Mutat Res. 665:44–50. 2009. View Article : Google Scholar
|
|
39
|
MacDonald IM, Smaoui N and Seabra MC:
Choroideremia. GeneReviews® [Internet]. Pagon RA, Adam
MP, Bird TD, Dolan CR, Fong CT, Smith RJH and Stephens K:
University of Washington; Seattle: pp. 1993–2014. 2003
|
|
40
|
Lee TK, McTaggart KE, Sieving PA, et al:
Clinical diagnoses that overlap with choroideremia. Can J
Ophthalmol. 38:364–372. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Roberts MF, Fishman GA, Roberts DK, et al:
Retrospective, longitudinal, and cross sectional study of visual
acuity impairment in choroideraemia. Br J Ophthalmol. 86:658–662.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mura M, Sereda C, Jablonski MM, MacDonald
IM and Iannaccone A: Clinical and functional findings in
choroideremia due to complete deletion of the CHM gene. Arch
Ophthalmol. 125:1107–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
MacDonald IM, Russell L and Chan CC:
Choroideremia: new findings from ocular pathology and review of
recent literature. Surv Ophthalmol. 54:401–407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang Q, Zulfiqar F, Xiao X, et al: Severe
retinitis pigmentosa mapped to 4p15 and associated with a novel
mutation in the PROM1 gene. Hum Genet. 122:293–299. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xiao X, Mai G, Li S, Guo X and Zhang Q:
Identification of CYP4V2 mutation in 21 families and overview of
mutation spectrum in Bietti crystalline corneoretinal dystrophy.
Biochem Biophys Res Commun. 409:181–186. 2011. View Article : Google Scholar
|
